Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Meningeal Carcinomatosis 2Lung Neoplasms 2Respiratory Tract Neoplasms 1Pleural Effusion, Malignant 1NSCLC 1Bronchial Neoplasms 1Advanced Non-small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

sugemalimab 1aldesleukin 1aflutinib 1X-Rays 1Pharmaceutical Preparations 1Metformin 1Interleukin-2 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion, Malignant × aflutinib × 90 days × Clear all
NCT07482605 2026-03-20

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Jiangmen Central Hospital

Phase 2 Not yet recruiting
63 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡